U.S. Retail REITs Stock News

Toast (TOST) is back in focus as investors weigh its push into enterprise chains, retail, international markets, and new tools like Toast Drive-Thru and Toast IQ, which are reshaping the company’s restaurant technology model. See our latest analysis for Toast. Against that backdrop, Toast’s share price has risen 23.23% over the past month and 3.44% over 90 days, yet is still down 11.58% year to date, while the 1 year total shareholder return has declined 35.34% and the 3 year total...

Cognizant Technology Solutions (CTSH) is stepping up its AI and cyber defense efforts, joining OpenAI’s Daybreak Cyber Partner Program, expanding Gemini Enterprise work with Google Cloud, and scaling a Frontier-certified workforce. See our latest analysis for Cognizant Technology Solutions. Despite the AI and cyber defense push, Cognizant Technology Solutions has seen its 30 day share price return fall 8.3%, contributing to a year to date share price decline of 44.9%. The 1 year total...

Recent interest in Dave (DAVE) centers on the company’s decision to appoint Gopi Kuchimanchi as Chief Technology Officer, an internal promotion that highlights leadership continuity in its AI driven underwriting and core banking infrastructure. See our latest analysis for Dave. Against this backdrop, Dave’s share price has been strong, with a 30 day share price return of 54.08% and a year to date share price return of 100.67%. The 3 year total shareholder return is very large at around 80x,...

With US inflation easing to 3.5% and gas prices pulling headline figures lower, investors are again weighing how persistent high living costs might affect essential spending. Consumer staples stocks sit at the center of that debate, as households still need food and household goods even when budgets feel tight. This article looks at 3 stocks from a Consumer Staples Stocks screener that appear closely exposed to the latest inflation news. Each company may react differently to easing price...

Ultragenyx Pharmaceutical (RARE) stock continues to trade with recent moves shaped largely by its rare disease portfolio and late stage pipeline. This has prompted investors to reassess risk, growth potential, and current valuation. See our latest analysis for Ultragenyx Pharmaceutical. At a share price of $29.28, Ultragenyx Pharmaceutical has seen short term pressure, with a 1 day share price return down 3.11% and 7 day share price return down 13.42%. This is set against a 90 day share price...

Dollar General stock has delivered a steep 40.3% decline over the past 5 years, yet current valuation checks and intrinsic value work both suggest the shares now trade at a discount to what the underlying business may be worth. Over 5 years, Dollar General shareholders are down 40.3%, which sets expectations for a potential reset in how the stock is priced relative to its fundamentals. Rising gas prices and household cost pressures can support revenue as consumers trade down to discount...

Haemonetics (HAE) has drawn attention after recent share price moves, including a gain of about 7% over the past month and roughly 26% over the past 3 months. These changes are prompting closer examination of its fundamentals. See our latest analysis for Haemonetics. At a share price of $77.86, Haemonetics shows recent momentum with a 30 day share price return of 7.05% and a 90 day share price return of 26.36%. This is set against a more modest 1 year total shareholder return of 7.32% and a 3...

SoFi Technologies stock has delivered an 83.2% gain over the past three years, yet the latest valuation work suggests the shares trade at a premium, with both the intrinsic value estimate from the Excess Returns model and the market multiples pointing to overvaluation. The 83.2% return over three years puts SoFi in the category of stocks that have already rewarded shareholders. This can leave less room for error if expectations change. Growth in SoFi's banking and broader financial services...

Partner trial for Darzalex Faspro using Halozyme's ENHANZE technology reported significant survival benefits for multiple myeloma patients. Late stage study results point to improved outcomes for people receiving this subcutaneous therapy. News is material for Halozyme Therapeutics (NasdaqGS:HALO) as it relates directly to one of its key partnered medicines. Halozyme Therapeutics centers its business on ENHANZE, a drug delivery technology licensed to large biopharma partners. The latest...

Hexcel (HXL) stock is drawing fresh attention after the company confirmed it will showcase its latest high performance composite materials and pursue new industry partnerships at the 2026 Farnborough International Airshow. See our latest analysis for Hexcel. The Farnborough announcement comes after a strong run in Hexcel’s stock, with a 16.96% 90 day share price return and a 73.23% 1 year total shareholder return signalling building momentum at the current US$103.81 share price. If Hexcel’s...

Arch Capital Group (ACGL) has caught investors’ attention after a 9.7% stock return over the past month, coinciding with updated earnings estimates that point to a 5% year-over-year decline this quarter. See our latest analysis for Arch Capital Group. Looking beyond the past month, Arch Capital Group’s 1 year total shareholder return of 14.71% and 5 year total shareholder return of 176.62% sit alongside a 7.98% year to date share price return. This suggests momentum has been building despite...

Visteon (NasdaqGS:VC) has entered new multi year partnership agreements to secure advanced memory and storage supplies for automotive applications. The company is part of Micron's newly completed Strategic Customer Agreements alongside other major automotive suppliers and partners. The partnerships focus on long term supply and technology planning for next generation, AI enabled vehicle platforms. Visteon sits at the intersection of automotive electronics and software, supplying cockpit...

After several years where Clorox stock has fallen about 38% over 5 years, current valuation checks point in the opposite direction, with both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggesting the shares may now be pricing in relatively low expectations. The share price decline of roughly 38.2% over 5 years signals that investors have been marking Clorox down, even before considering today’s valuation signals. Expectations for pressured margins and softer...

Rare earth metal stocks sit at the crossroads of technology, defense, and the clean energy buildout. Today’s mixed global backdrop, from steady US bond yields to shifting industrial output in Asia and Europe, keeps attention firmly on supply security for these materials. With only a limited pool of companies focused on mining these critical elements, a targeted Rare Earth Metal Stocks screener can help you cut through market noise and focus on pure exposure to this theme. This article...

Earlier this month, the UK Ministry of Defence awarded Omnia Training a £2.00 billion, 15-year contract to become the British Army’s Strategic Training Partner, with a RaytheonUK-led consortium delivering a digitally enabled collective training system that blends virtual, synthetic and data-driven environments. This win underlines RTX’s deepening role in high-tech military training and synthetic environments, reinforcing its broader push into advanced defence technologies and integrated...

Natera (NTRA) stock is in focus after two key developments: a final local coverage determination expanding Prospera transplant test access and stronger than expected revenue growth supported by higher testing volumes. See our latest analysis for Natera. Natera’s recent developments appear to be reflected in its share price, with a 30.2% 90 day share price return and a very large 3 year total shareholder return that suggests momentum has been building over a longer period. If Natera’s move has...

How Eversource Energy Stock Has Been Performing Eversource Energy (ES) has been trading without a clear single news catalyst, so investors are focusing on how the stock has moved recently and how that lines up with its fundamentals. Over the past month, the stock has gained about 8%, and over the past 3 months it is up roughly 7.8%. Year to date, Eversource Energy shows a total return close to 9.6%, with the 1 year total return around 19.3%. On a longer view, the 3 year total return stands...

eToro Group stock has fallen 36.6% over the past year, yet the latest valuation checks are split, with the Excess Returns intrinsic value estimate pointing to a premium while market based multiples still screen the shares as relatively cheap. That tension between a weak share price track record and conflicting valuation signals is what investors are trying to make sense of today. Over the last 12 months, eToro Group is down 36.6%, which puts recent enthusiasm around the stock against a still...

Greenbrier Companies stock has delivered a 37.0% total return over the past 5 years, yet the latest valuation checks point to a mixed picture rather than a clear bargain or clear premium at the current US$50.02 share price. Over 5 years, a 37.0% return suggests Greenbrier Companies has rewarded patient shareholders, which naturally raises the bar for fresh upside from here. Future demand for railcars and related services can support earnings and cash flow, while any pressure on manufacturing...

Earlier this week, Scotts Miracle-Gro reported that strong demand in its core U.S. Consumer segment coincided with progress on innovation, acquisitions, cost-saving measures, and supply chain enhancements, alongside the divestiture of its Hawthorne business to streamline operations. This combination of refocusing on the core consumer franchise and exiting Hawthorne is drawing attention to how a leaner structure could affect earnings quality and operational consistency. Now, we’ll explore how...

Grand Canyon Education (LOPE) has drawn investor attention after a period of mixed share performance, with the stock down over the past week, month, past 3 months, and in the year to date. See our latest analysis for Grand Canyon Education. With the share price at US$140.44 and the 90 day share price return down 19.71%, recent weakness follows a softer year to date pattern. However, the 3 year total shareholder return of 28.73% and 5 year total shareholder return of 52.49% still reflect a...

Ciena stock has delivered a very large three year gain of roughly 7.8x, yet the company now sits in an unusual valuation split where the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside while earnings based multiples suggest the shares are expensive compared with peers. Over the past three years, Ciena has returned roughly 7.8x, so the current debate centers on how much of the company’s potential is already reflected in the price. Progress in quantum safe data...

ACI Worldwide stock has surged over the past three years, yet the valuation picture is mixed, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the shares trade below that estimate while the broader checks still do not flag the stock as a clear bargain. ACI Worldwide has returned 150.3% over the past three years, which puts extra focus on whether the current price still leaves room above intrinsic value or mainly reflects past gains. Recent news...

The tariff clock is ticking for U.S. auto manufacturers, and the expiry of President Trump's temporary 10% global tariff has put fresh attention on which stocks may be positioned to cope with the next round of trade policy changes. With new, potentially more permanent duties on the horizon, investors are reassessing how global supply chains, import exposure, and cost structures could affect returns. This article walks through three stocks from a U.S. domestic auto manufacturers screener that...